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Abstract
Ergot alkaloid synthetic capacity of Penicillium camemberti
Samantha Fabian

Penicillium camemberti plays a major role in the ripening process of brie and
camembert type cheeses. Investigation of the recently sequenced P. camemberti
genome revealed the presence of a cluster of five genes previously shown to be
required for ergot alkaloid synthesis in other fungi. Clustered with the five ergot alkaloid
synthesis genes (aka eas genes) were two additional genes with that had the apparent
capacity to encode enzymes involved in secondary metabolism. We analyzed samples
of brie and camembert cheeses as well as cultures of P. camemberti grown under
different conditions and were not able to detect any known ergot alkaloids, indicating the
P. camemberti eas genes were either not expressed or encoded non-functional
enzymes. We used a heterologous expression strategy to investigate the theoretical
biosynthetic capacity of P. camemberti. Based on studies with the related ergot
alkaloid-producing fungus Neosartorya fumigata (syn. Aspergillus fumigatus), the five
known eas genes found clustered in the P. camemberti genome should give the fungus
the capacity to produce the ergot alkaloid chanoclavine-I aldehyde. We used a
chanoclavine-I aldehyde-accumulating mutant of N. fumigata as a recipient strain in
which to express the two uncharacterized P. camemberti eas cluster genes (named
easH and easQ) to create a functioning facsimile of the P. camemberti cluster.
Expression of easH and easQ in the chanoclavine-I accumulating N. fumigata resulted
in the accumulation of a pair of compounds of m/z 269.1 in positive mode LC-MS.
Since this m/z is consistent with the mass of the isomeric pair of [rugulovasine A/B + H],
we analyzed a culture of the related rugulovasine producer Penicillium biforme and
found the same isomeric pair of analytes. Fragmentation of the analytes yielded
fragments typical of those resulting from fragmentation of rugulovasine A/B. The
deduced activities of the products of easH and easQ catalyze theoretical reactions that
provide a reasonable pathway from the precursor chanoclavine-I aldehyde to the
products rugulovasine A/B. When individually studied, the chanoclavine-I aldehydeaccumulating mutant of N. fumigata transformed with the P. camemberti easQ gene
yielded a ratio of analytes at m/z 271.1 vs. m/z 255.1 that support the theorized
mechanisms of easH and easQ to produce rugulovasines. The P. biforme genome
contains a homologous eas cluster with only 12 mutations relative to that of P.
camemberti. Eleven of the 12 mutations were investigated via complementation studies
of the mutated genes (dmaW, easC, easE) using knockout strains of N. fumigata. The
data indicate that P. camemberti has the genes to produce the ergot alkaloid
rugulovasine A/B but that during domestication isolates that failed to produce alkaloids
were selected for.
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Introduction/ Literature Review
P. camemberti history and importance
Camembert type cheeses were thought to be first made in 1791 in the village of
Camembert, near Normandy, France by Marie Harel (Spinnler and Gripon, 2004). While
Camembert is a popular choice for U.S. consumers today, it holds historical significance
in French culture. The WWI French troops were famously issued the cheese in their
military rations and thus it gained popularity. The process of this making cheese is
highly dependent on P. camemberti. Without the fungus, the cheese would not have
the characteristic flavor and texture, as the mold plays a crucial part in the ripening
process.
During the initial stages of the cheese making process, the milk is inoculated with
P. camemberti as well as bacterial cultures and renin. As the cheese matures, the
fungus colonizes the entire outside surface area giving the cheese its characteristic
white felt rind. Perhaps the biggest contribution P. camemberti has to the ripening
process is its ability to oxidize lactate, as the lactate is the main food source for the
fungus (McSweeny, 2004). As a result of the lactate metabolism, gradients are
established that help with the transport of other compounds from the middle of the
cheese to the surface rind. P. camemberti oxidizes lactate to CO2 and O2 and over time
results in increasing the pH of the rind of the cheese (McSweeny, 2004). This
deacidification leads to the creation of a pH gradient from the cheese center to the rind
which allows lactate to move to the rind surface, where it is oxidized by P. camemberti.
The increase in pH on the rind also creates a calcium phosphate gradient, which allows
migration of calcium and phosphate from the center to the cheese surface. The
proteolysis by P. camemberti on the rind creates an excess of ammonia, which diffuses
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into the cheese giving it its distinct odor. The initial oxidation of the lactate of the cheese
is key in its production as it continues until all of the available lactate is metabolized.
The degradation of protein in camembert cheeses is very complex and involves
many different microorganisms including lactic acid bacteria. However, P. camemberti
contributes to the proteolysis of the cheese by making aspartyl and metalloproteinases,
acid carboxypeptidase and an alkaline aminopeptidase (McSweeny, 2004). The aspartyl
proteinases acts on α-casein, while the acid carboxypeptidases work on β-casein,
hydrolyzing the Lys97-Va98l, Lys99-Glu100, and Lys29-Ile30 bonds (McSweeney &
Fox, 2004). In the process of lipolysis, the milk itself contains lipolytic agents such as
lipoprotein lipase. The renin coagulant and the starter microorganisms can also provide
lipases that can metabolize the lipids present. P. camemberti has been found to oxidize
linoleic and linolenic acids with lipoxygenases and hydroperoxide-lipases. It is capable
of producing 9-, 10-, and 13-hydroperoxy acids from polyunsaturated fatty acid oxidation
(Spinnler and Gripon, 2004). However, there is minimal lipolysis occurring in the
cheese as the high lipid concentrations give the cheese its creamy texture.
Gene clusters and secondary metabolites
Fungi have interesting clusters of genes that encode the ability to produce
secondary metabolites, or chemical compounds that can be beneficial in some way for
the fungi. These clusters can code for catabolic pathways, activated to allow the fungus
to survive under low nutrient/competitive environments by using low molecular weight
nutrients as energy source (Keller and Hohn, 1997). They also code for enzymes that
act as catalysts of biosynthetic pathways producing secondary metabolites (Keller and
Hohn, 1997). While there are many, some common examples include penicillin and
ergot alkaloids. The secondary metabolites can be beneficial or sometimes harmful to
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plants, humans and animals. Secondary metabolite production is controlled by the
activation/deactivation of the transcription of certain genes that are found in a cluster
(Brakhage and Schroeckh, 2011). These gene clusters are unique to the chemical
compound being produced but can be found in an array of different fungi. On another
note, the discovery of these gene cluster does not mean the fungus is producing the
metabolite, but rather that it has the potential to produce it.
Examples of secondary metabolites produced by Penicillium species
Penicillium species are producers of many secondary metabolites such as the
well-known antibiotic penicillin. P. camemberti has been known to produce
acetaldehyde, benzaldehyde, 3-methylbutanal and 1-octen-3-ol to inhibit the bacteria
Listeria monocytogenes and Salmonella typhimurium (Larsen and Knochel, 1997). It is
believed that the production of these chemicals is beneficial to P. camemberti as it
reduces the competition of these potentially pathogenic gram negative/gram positive
bacteria by inhibiting their growth. Additionally, P. roqueforti the fungus associated with
the production of blue/roquefort cheese has been known to make antibiotics such as
penicillin, as well as mycophenolic acid and patulin (Neilsen et al., 2006). P. roqueforti
is also known for making ergot alkaloids festuclavine, isofumigaclavine A and
isofumigaclavine B (Neilsen et al., 2006). Festuclavine is also made by P. crustosum, P.
palitans and P. oxalicum (Kozlovsky, 1999) Therefore, it is not uncommon for
Penicillium species to produce ergot alkaloids.
Ergot alkaloids
Ergot alkaloids are most famously produced by the fungus Claviceps purpurea
and also are produced by a large range of other fungi including Epichloë spp. and
Neosartorya fumigata (Panaccione and Coyle, 2005). They can also be produced by
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certain Penicillium spp. that were previously discussed (Kozlovsky, 1999). Ergot
alkaloids can be viewed as beneficial or harmful depending on the dose and context.
Ergot alkaloid derivatives can be used directly or often are modified to serve as
pharmaceuticals as well as illegal drugs, such as lysergic acid diethylamide or LSD. The
most popular legal ergot alkaloid-derived drugs produced are for treating migraines,
depression, prolactin disorders, gynecological issues, dementia and Parkinson’s
(Hulvova et at., 2013). The known fungal producers of these alkaloids are grown under
optimal alkaloid production settings and then the alkaloids are extracted for use.
However, ergot alkaloids can be harmful if consumed without any chemical modification
or in uncontrolled doses. Ergot alkaloid poisoning, or ergotism, can cause a wide range
of symptoms from hallucinations, gangrene, burning skin, neurological diseases and
even death. Ergotism can occur in both humans and animals. Today, the incidence of
ergotism is uncommon due to modern farming practices, but high levels of ergot
alkaloids can still be found in the grasses of less advanced farming systems.
Historically, ergotism was a widespread problem that was referred to as St. Anthony’s
Fire that swept across Europe and the early American colonies. The largest epidemic of
ergotism occurred in 994 AD in Aquitaine, France where around 40,000 people died as
a result (VanDongen and DeGroot, 1995).
Mechanism of action
The above-mentioned benefits and dangers of ergot alkaloids can be explained
by the mechanism in which they affect the body. Because they have a similar chemical
structure to the neurotransmitters dopamine, serotonin and norepinephrine, ergot
alkaloids interact with the receptors for those neurotransmitters (Tudzynski et al., 2001).
Figure 1 highlights the similarity among an alkaloid and three neurotransmitters.
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However, the way the alkaloids interact with the neurotransmitters depend on the
alkaloids structure and the particular sub-type of receptor. In some cases, ergot
alkaloids act as agonists, whereas in other cases they are antagonists. Adding different
chemical substituents to C-8 of the ergoline ring gives the alkaloid different affinities
toward the different neuroreceptors (Schardl et al., 2006). Simple peptide ergot
alkaloids have a high affinity for adrenergic receptors and thus are responsible for the
vasoconstrictive effects. However, the clavines have a high affinity for serotonin
receptors and therefore responsible for the anti-serotoninergic action. Some ergot
alkaloids can also have an effect on prolactin release and are therefore manipulated for
pharmaceutical use for conditions like galactorrhea (Schardl et al., 2006).
Chemistry of ergot alkaloids
Chemically, the backbone of the alkaloids consists of 3,4-substituted indole
derivatives with a tetracyclic ergoline ring structure (Tudzynski et al., 2001). There are
three group classes of ergot alkaloids: clavines, lysergic acid amides, and ergopeptines
based on their level of complexity and additional groups (Panaccione, 2005). The
alkaloids are synthesized from the amino acid tryptophan and then metabolized into
various pathway end products via enzymatic reactions. The enzymes are coded for by
ergot alkaloid synthesis or Eas genes.
Genes of the ergot alkaloid synthesis cluster
The publicly available genome of P. camemberti features five ergot alkaloid
synthesis (eas) genes in its genome: dmaW, easC, easE, easF, and easD. In N.
fumigata, these genes code for the enzymes that catalyze synthesis of DMAPP and
tryptophan into chanoclavine-l aldehyde (Figure 2; Figure 3). More specifically, the
dmaW gene encodes for the enzyme dimethylallyltryptophan synthase which converts
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tryptophan and DMAPP to dimethylallyltryptophan or DMAT (Wang et al., 2004; Coyle
and Panaccione, 2005). The easF gene is responsible for coding for the enzyme
dimethylallyltryptophan-N-methylase which converts DMAT to N-Me-DMAT (Rigbers
and Li, 2009). Genes easC and easE code for the enzymes catalase and chanoclavinesynthase, respectively (Lorenz et al., 2010; Goetz et al., 2011). While the exact
mechanism is unknown, it is known that they work together to form chanoclavine-I
(Goetz et al., 2011). The enzyme chanoclavine-I dehydrogenase coded by the easD
gene then converts chanoclavine-I to chanoclavine-I aldehyde (Wallwey et al., 2011).
This gene cluster and production of chanoclavine-I aldehyde from tryptophan and
DMAT is common to most ergot alkaloid producers such as Claviceps/Epichloë and
Neosartorya/Penicillium. At this point, the synthesis of the specific ergot alkaloids
produced by the different species is catalyzed by different enzymes in lineage-specific
branches.
Susceptible to evolution adaptability and mutability of Penicillium species
Multiple lines of evidence have led to the idea that Penicillium species are readily
susceptible to evolutionary processes. One such example of evolutionally adaptation is
the concept of horizontal gene transfer between different species of Penicillium. P.
camemberti and P. roqueforti are known to undergo these gene transfers frequently with
each other. While these two species of Penicillium are both primarily grown on dairy
substrates and are used to produce cheese, phylogenetically they are not closely
related (Cheeseman et al., 2014). However, they were found to undergo the same
horizontal gene transfers of two genes that give the fungi fitness and competitive
advantages in a cheese environment (Cheeseman et al., 2014).
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Penicillium biforme: A close ancestor
While P. camemberti is a characteristically white mold found exclusively in
cheese products, it is a descendent of Penicillium biforme and Penicillium fuscoglaucum
which are blue/gray type molds (Ropars et al., 2015). Because of its close relation to P.
camemberti, P. biforme was also studied as part of this thesis project. P. biforme
naturally occurs in cheese substrates but has been found to be a contaminant in other
dairy-based foods and juices as well. P. bifome is a known producer of the ergot
alkaloid rugulovasine (Dorner et al., 1980). Like other known ergot alkaloid producers,
my preliminary investigation of its publicly available genome indicated it has the first five
ergot alkaloid synthesis genes along with two additional genes, easH and easQ (Figure
3). Thus, the ability of P. camemberti to produce ergot alkaloids was studied due to its
close relation to P. biforme and its importance in the production of camembert cheese.
Rationale and hypothesis:
Due to the previously studied activities of the five ergot alkaloid synthesis genes
found in P. camemberti, the ability of this fungus to produce ergot alkaloids was
researched. Considering that other Penicillium species are capable of producing
alkaloids and rapidly evolving, it is reasonable to hypothesize that P. camemberti has
the capacity to produce ergot alkaloids. With P. biforme phylogenetically being a recent
ancestor to P. camemberti, it could be that during domestication mutations caused this
gene cluster to no longer function in P. camemberti.
Methods
Characterization of P. camemberti and P. biforme ergot alkaloid gene clusters
The ergot alkaloid gene cluster in P. camemberti was found by comparing
individual eas genes from N. fumigata to the NCBI database. Contigs containing P.
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camemberti and P. biforme eas gene clusters were downloaded and additional genes
were annotated by BlastX searching individual, contiguous 5-kb fragments.
HPLC analysis
Fungi were cultured on malt extract agar (6g malt extract, 1.8 maltose, 6g
dextrose, 1.2g yeast extract per liter of distilled water) for 7 to 10 days, and samples
were prepared for HPLC analysis by cutting a 1 cm by 1 cm piece of fungus-colonized
medium and adding it to 400 μL of HPLC grade methanol. Samples were rotated endover-end (15 rpm) for 35 minutes and centrifuged at 13,000 rpm for 10 minutes. One
hundred μL of supernatant was placed into an HPLC sample vial and 20 μL was
analyzed for ergot alkaloids on reverse phase liquid chromatography using a C18
column and the protocol outlined in Panaccione et al. (2012). Analytes were monitored
by fluorescence with excitation at 272 nm and the emission 372 nm. The area under the
peaks were measured and converted into ng/mL using a standard curve generated from
prior HPLC data.
Liquid chromatography mass spectrometry (LC-MS) analysis
Samples were prepared for LC-MS by using 5 mL of 100% methanol to remove
all spores and hyphae from the malt extract agar cultures grown for 7-21 days. Two mL
of the harvested spore suspension was centrifuged at 13,000 rpm for 10 minutes. The
supernatant was collected and concentrated to 100 μL in a speedvac. Ten μL of the
extract was then analyzed with a Thermo Fisher LCQ LC-MS according to methods
described by Ryan et al. (2013) except the gradient program initiated with 86% mobile
phase A (5 parts acetonitrile + 95 parts 0.1% formic acid) and 14% mobile phase B
(75% acetonitrile arts acetonitrile + 95 parts 0.1% formic acid) and increased linearly to
100% mobile phase B over 20 minutes. Flow was maintained at 100% B for 5 min,
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before initial conditions were restored. Flow rate was 200 μL/min. The peaks in the
chromatograms of interest were measured using the LC-Qual browser and analyzed for
the observation of conversion ratios.
Fungal transformation protocol
Cultures for preparing protoplasts for transformation were grown as follows. A 2cm x 2-cm sample of fungus–colonized malt extract agar of various strains of N.
fumigata was used as inoculum to start cultures in 50 mL of malt extract broth. Cultures
were incubated overnight at 37°C, 80 rpm. To prepare protoplasts, the broth was
replaced with 15 mL 0.7 M NaCl that included 40 mg lysing enzyme (Sigma-Aldrich, St.
Louis, MO) and 1 g VinoTaste Pro (Gusmer Enterprises Inc., Mountainside, NJ). The
enzyme-mycelium mixture was then incubated for 2 hours at 37°C and 80 rpm. The
mixture was filtered through a miracloth (EMD Chemicals, Gibbstown, NJ) lined funnel
in order to separate the protoplasts from the hyphae and other debris. The protoplasts
were pelleted by centrifuging for three minutes at 3000 rpm. The supernatant was
decanted, and then the protoplasts were resuspended with 10 mL 0.7 M NaCl and then
re-pelleted. The process was then repeated but with resuspension in 5 mL STC (1 M
Sorbitol, 0mM Tris pH 7.4, 10m 6M CaCl2). The protoplasts were then resuspended in a
final volume of STC that allowed for a protoplast concentration of 5x10 6 protoplasts in
100 µL STC. Two volumes of 37.5% PEG 8000 and one volume of PEG amendments
(1.8 M KCl, 150 mM CaCl2, 150 mM Tris pH = 7.4) were mixed together in order to
prepare a polyethylene glycol (PEG) solution. A quarter of the final protoplast volume
was calculated, and then the prepared PEG was added in that amount. Ten μL of
plasmid DNA or PCR product was added to the 125 μL of the final protoplast mixture,
which was incubated on ice for 30 minutes. One mL of the PEG solution was added to
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the cells and then the mixture was incubated at room temperature for 20 minutes. The
solution was then divided among three Petri dishes and mixed with 15 mL molten
TM102 media, which corresponds to M102 medium as defined by Rykard et al. (1982)
but containing 1 M sucrose. After the agar had solidified, 15 mL of molten TM102 mixed
with 800 µg/mL phleomycin (InvivoGen, San Diego, CA) was added on top of solidified
layer. The plates were incubated at 37 °C for three days.
Preparation of gene constructs for fungal transformation
A typical PCR reaction was comprised of 11 μL distilled/deionized water, 5 μL 5x
Phsuion HF buffer (100 mM KCl, 20 mM Tris-HCl pH 7.4, 1.5 mM MgCl2; Thermo
Scientific, Waltham, MA),4 μL 1.25 mM dNTPs, 1.25 μL 0.5 mM forward primer,1.25 μL
0.5 mM reverse primer, 2 μL of template DNA and 0.5 μL of Phusion high-fidelity
polymerase (Thermo Scientific).The reactions underwent the same general cycle, with
an initial denaturation at 98°C for 30s, followed by 35 cycles of 98°C (15 s), annealing
temperature (as defined by primer pair in Table 1) (15 s), and 72°C for and extension
time as defined in Table 1, followed by a final extension at 72°C for 60 s. The primers,
annealing temperatures, and extension times are included in Table 1. The PCR
products were cleaned using the Zymogen DNA Clean & Concentrator kit (Zymo
Research Corp., Irvine, CA). The cleaned products observed via gel electrophoresis in
0.8% agarose.
Plasmid preparation
Various restriction enzyme sites were included in the primers used to PCR
amplify different gene fragments. The PCR products with restriction enzyme sites were
cleaned using the Zymogen DNA Clean & Concentrator kit (Zymo Research Corp.,
Irvine, CA) and then digested with the appropriate restriction endonuclease for 90
minutes at 37°C. The following solution mix was used for all digestions: 6 μL of cleaned
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PCR products with restriction sites, 10 μL distilled water, 2 μL of CutSmart buffer (New
England BioLabs, Ipswich, MA) and 1 μL each of the corresponding restriction enzymes
associated with the specific gene products. A previously prepared pBCPhleo PCR
product was also digested under the same conditions with the same set of restriction
enzymes used for the individual gene PCR product. The digested products were
cleaned using the Zymogen DNA Clean & Concentrator kit. The cleaned digests were
loaded on a 0.8% agarose gel and the intensities of the products were recorded. A
ligation reaction was created based on the observed intensities of the digested
fragments, with 8 μL of the mixture being comprised of a ratio of the amplified gene
digest and the digested pBCphleo; along with 1 μL of 10x ligation buffer and 1 μL of
ligase (New England BioLabs, Ipswich, MA). The solution was incubated at 16°C
overnight. The ligation was then transformed into a Novagen NovaBlue™ Competent E
.coli cells (EMD Biosciences Inc, Darmstadt, Germany) and grown on LB +
chloramphenicol (50 μg/mL) agar. Resulting colonies were isolated and grown in 2 mL
of LB + chloramphenicol broth and incubated at 37°C overnight. The cells were pelleted
and the plasmids were purified using the Zyppy™ Plasmid Miniprep kit (Zymo Research
Corp., Irvine, CA).
Expression of of easQ/easH Fusion PCR product in N. fumigata
The easH and easQ genes of P. camemberti were individually PCR amplified
using primer sets 13 and 14 (Table 1). The cleaned PCR products were then then
attached to a N. fumigata easA/easG bidirectional promoter via fusion PCR. The
previously generated easH, easQ and a previously generated N. fumigata promoter
PCR products were used as template DNA and the primer set 15 (Table 1). The 4145bp fusion PCR product along with a previously created pBCphleo linear plasmid were
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co-transformed in an equal molar concentration into a previously created chanoclavine-l
aldehyde accumulating easA ko strain of N. fumigata (Coyle et al., 2010).
Transformants were analyzed by HPLC with fluorescence detection and LC-MS.
Observation of the individual function of P. camemberti easH and easQ
P. camemberti easH and easQ gene fragments with restriction enzyme sites
were PCR amplified using primers 11 and 12, respectively (Table 1). The easH
fragment contained restriction enzyme sites for NotI and BamHI, while the easQ PCR
product contained sites for NotI and SpeI. The PCR products were digested with their
corresponding restriction enzyme set, cleaned, and then ligated with pBCphleo. The
resulting plasmid was used for fungal transformation into the N. fumigata easA knockout
strain (Coyle et al., 2010). The successful transformants were analyzed by HPLC with
fluorescence detection along with LC-MS.
Functional analysis of P. camemberti easC, easE and dmaW
The functionality of P. camemberti easC, easE and dmaW was tested by using
those genes in attempted complementation of previously characterized N. fumigata
knockout mutants. The P. camemberti gene fragments were PCR amplified using
primer sets 1, 2 and 3 (Table 1) that included restriction enzyme sites. The easC
fragment contained sites for BamHI and EcoRI, easE featured sites for NotI and SpeI,
and dmaW had restriction enzyme sites for NotI and BamHI. The cleaned PCR products
were digested with the indicated restriction enzyme set, cleaned and then ligated with
similarly-digested pBCphleo. The resulting plasmids were used for fungal transformation
into previously made easC, easE and dmaW knockout strains of N. fumigata (Goetz et
al., 2011; Coyle & Panaccione, 2005). The transformants were plated on malt extract
agar plates and analyzed by HPLC with fluorescent detection.
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Extraction of messenger RNA and preparation of cDNA
Cultures of P. camemberti NRRL 874 were grown as surface cultures on malt
extract broth for three days at room temperature. A 100 mg sample of the fungal mat
was then frozen with liquid nitrogen and ground into a powder with a mortar and pestle.
RNA was then extracted by following the instructions of the Qiagen RNeasy Plant kit
(Qiagen Company, Hilden, Germany). cDNA was obtained by reverse transcribing the
mRNA with SuperScript IV reverse transcriptase (Thermo Scientific, Waltham, MA). The
cDNA was then used as template for primer sets 4, 5, 6, 7, 8, 9 and 10 (Table 1). PCR
products were analyzed via gel electrophoresis.
Analysis of different Penicillium spp. isolates and cheese prepared with P.
camemberti or P. biforme for ergot alkaloids
Cultures of P. camemberti NRRL 874, NRRL 875, NRRL 66321 and P. biforme
(P. camemberti NRRL strain 885) were grown on malt extract agar at 22°C for seven
days. Cultures were also analyzed via LC-MS analysis.
Samples of brie and camembert cheese bought commercially and those made in
lab were also analyzed using the same HPLC and LC-MS detection methods outlined
above. The lab generated cheese samples were made with mesophilic cheese culture
(New England Cheesemaking Supply Co., South Deerfield, MA) and P. camemberti
NRRL 874 and P. biforme NRRL 885 individually as the ripening fungi. Curds were
allowed to mature for eight weeks.

Results
Penicillium camemberti has an ergot alkaloid synthesis (eas) gene cluster with a
unique combination of eas genes
Prior research has established that the genes dmaW, easF, easC, easE, and
easD (Figure 3) encode the enzymes that catalyze the reactions that transform DMAPP

14

and tryptophan to chanoclavine-I aldehyde (Figure 2). Genomes of other fungi were
investigated for contigs that contain the eas genes through sequence queries. The
search revealed that P. camemberti contains an eas cluster containing homologs of
dmaW, easF, easC, easE, and easD (Figure 3;Table 2). This same observation has
recently been noted by Martin et al. (2017). Further analysis of the P. camemberti contig
that contained the eas gene cluster revealed a copy of the gene easH, alleles of which
have two very different functions in two different fungi (Havemann et al., 2014;
Jakubczyk et al., 2015) and also a copy of a novel gene with undetermined functionality,
referred to as easQ (Figure 3;Table 2). The presence of this combination of genes
indicated that P. camemberti has the genetic potential to produce chanoclavine-I
aldehyde, with the possibility that the products of easH and easQ genes modify
chanoclavine-I aldehyde into a more complex ergot alkaloid.
Penicillium camemberti alleles of easH and easQ contribute to ergot alkaloid
synthesis
Roles in ergot alkaloid biosynthesis for P. camemberti genes easH and easQ
were derived via transformation studies. The easH and easQ genes of P. camemberti
strain NRRL 874 were individually PCR amplified and then attached to a N. fumigata
easA/easG bidirectional promoter via fusion PCR. The easH/easQ fusion PCR product
was co-transformed along with pBC-Phleo into a chanoclavine aldehyde accumulating
easA ko strain of N. fumigata. Eight fungal transformant colonies grew on 400-µg/mL
phleomycin plates and were then analyzed by HPLC with fluorescence detection to
observe alkaloid accumulation. While chanoclavine aldehyde was detected, no novel or
additional alkaloids were observed in the HPLC analysis. DNA was extracted from the
transformants and studied via PCR to investigate the presence of the construct (Figure
4). A transformant that contained easH and easQ was further analyzed by LC-MS to
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compare its metabolite profile with that of the recipient easA ko strain of N. fumigata
(Figures 5 and 6). The transformed fungal strain was found to produce chanoclavine-I
(Figure 5C) and a pair of analytes with m/z values of 269.1288 (Figure 6). A pair of
compounds with the same molecular ion and retention times was produced by
Penicillium biforme (Figure 6), a close relative and proposed ancestor to P. camemberti
but not by the chanoclavine aldehyde-accumulating easA ko strain of N. fumigata used
as a recipient in this experiment (Figure 5). Prior research has established that P.
biforme produces of the isomeric pair of ergot alkaloids called rugulovasine A and
rugulovasine B, the [M+H]+ for each of which has a calculated m/z of 269.1285. Further
comparison of P. biforme and the easH/easQ-transformed easA ko strain of N. fumigata
via fragmentation analysis revealed that the two produced identical fragments, the m/z
values of which matched with the fragments produced upon fragmentation of
rugulovasine (De Medeiros et al., 2015) (Figure 6). The data indicate that that the
products of easH and easQ act on chanoclavine aldehyde to produce rugulovasines A
and B.
Individual functions of easH and easQ
While together easH and easQ were observed to produce rugulovasines from
chanoclavine-I aldehyde, the individual functions of the products of these genes were
also explored. P. camemberti easH gene under the control of the N. fumigata easA
promoter was transformed into the chanoclavine-I aldehyde-accumulating easA ko
strain of N. fumigata. Ten transformants containing the easH expression construct grew
on media containing 400 µg/mL phleomycin, indicating that those cultures had taken up
the phleomycin resistance-conferring construct. PCR analysis of genomic DNA template
demonstrated that the transformant contained the introduced easH gene (Figure 7A).
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RT-PCR analysis of cDNA template demonstrated that the easH mRNA was transcribed
in the transformant (Figure 8A), indicating that the gene was being expressed.
Sequence analysis and prior research indicates that both EasH and EasQ may be
oxidases. Thus it is likely that they may be adding an oxygen to chanoclavine-I
aldehyde. This addition would result in the m/z value observed for chanoclavine-I
aldehyde increasing from 255 to 271. Therefore, special attention was paid in LC/MS
analyses for appearance or increase in analytes with m/z of 271. The transformed strain
was analyzed for accumulation of ergot alkaloids by HPLC with fluorescence detection
and by LC-MS, but no novel peaks or ratios were observed as compared to the profile
of the N. fumigata easA knockout. EasQ was studied in the same manner, by
transforming the chanoclavine-I aldehyde accumulating easA ko strain of N. fumigata
with the P. camemberti easQ gene linked with the N. fumigata easA promoter. PCR and
RT-PCR analyses indicated the gene was present and transcribed (Figure 7B; Figure
8B). HPLC with fluorescence detection did not reveal the presence of any novel
metabolites when only a single gene was expressed. However, when analyzed on LCMS it was observed there was a large peak at m/z in the easQ transformant. This m/z
271 peak was also observed in the N. fumigata easA knockout and the easH
transformant, but in very small quantities. Thus, it was hypothesized that the m/z 271
product may be the oxidation product of the m/z 255 analyte (chanoclavine-l aldehyde)
and that the ratios of these anayltes may differ between strains. The areas under the
EIC peaks were then measured and analyzed using ANOVA. It was found that the ratios
were significantly different based on the measured strain (p=0.0017). A Tukey’s multiple
comparison test showed that the N. fumigata easA with the easQ gene had a much
higher m/z 271 to m/z 255 ratio than the N. fumigata easA knockout strain (p=0.002) or
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the easH transformned N.fumigata easA knockout (p=0.007), supporting the hypothesis
that EasQ oxidized chanoclavine-I aldehyde to a molecule with m/z 271 (Figure 9; Table
3).
Investigation of the lack of accumulation of ergot alkaloids in P. camemberti
strain NRRL 874
Possible reasons for lack of accumulation of rugulovasine in P. camemberti
include lack of expression of eas genes, misprocessing of eas gene transcripts, or null
mutations in individual eas genes. Whether the eas genes of P. camemberti were
transcriptionally active was investigated in qualitative RT-PCR analyses. Messenger
RNA from dmaW, easF, easC, easE, easD, easH and easQ were present in reverse
transcriptase-PCR analyses indicating that those genes are being transcribed in P.
camemberti strain NRRL 874 when grown in malt extract broth (Figure 10).
Additionally, sequencing results proved that the mRNAs were being processed properly,
as the cDNA contained open reading frames corresponding to those for functional eas
genes from N. fumigata.
The possibility that individual eas genes of P. camemberti were mutated was
investigated by comparing the P. camemberti eas gene cluster to the functional eas
cluster of P. biforme. The contig of P. biforme that contains its eas gene cluster was
obtained from NCBI GENbank (accession number CBXO010000115.1) and compared
to the P. camemberti eas gene cluster (GenBank accession CBVV010000119.1) by
Blast analysis. The two eas clusters were nearly identical, with the exception of five
differences in the coding regions of eas genes and seven intergenic differences or
polymorphisms (Figure 11). Each of the five polymorphisms that occurred within coding
sequences resulted in changes in amino acids in four different enzymes (Figure 11C).
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Two amino acid changes occurred in EasE, one in EasC, one in DmaW, and one in
EasQ.
In order to test functionality of the P. camemberti eas genes, three of the four
genes that contained SNPs relative to the established functional homologs in P. biforme
were transformed into previously constructed N. fumigata knockout strains; the function
of EasQ was evident from its co-expression with EasH in N. fumigata strain easA ko.
Transformation with P. camemberti dmaW and easE complemented the respective N.
fumigata mutants. Transformed strains that contained the dmaW or easE constructs
each accumulated fumigaclavine C, indicating that the P. camemberti allele restored the
N. fumigata ergot alkaloid pathway (Figure 12; Figure 7C-D). Attempts to complement
an easC knockout mutant of N. fumigata (Goetz et al., 2011) did not result in a strain
that expressed easC, thus the function of the EasC enzyme could not be assessed.

Analysis of potential ergot alkaloid accumulation in cheese
Four different wheels of Camembert cheese were cultured and ripened with P.
biforme NRRL strain 885 and P. camemberti NRRL strain 874 for eight weeks (Figure
13). Samples were analyzed by LC-MS along with a sample of P. biforme grown on malt
extract agar for comparison. Rugulovasine was not detected in any camembert cheese
sample. Samples of commercial cheese ripened with P. camemberti also were
investigated and found to be free of rugulovasine and chanoclavine-I.
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Discussion
My data illustrates that P. camemberti previously had the genetic capacity to
produce ergot alkaloids such as chanoclavine-I and rugulovasines A and B. My
research also has identified a new ergot alkaloid biosynthesis gene (easQ), provided
evidence for a novel functionality of an allele of the gene easH, and indicated a
biosynthetic pathway for the rugulovasine class of ergot alkaloids. The transformation
of easH and easQ into the chanoclavine-I aldehyde-accumulating easA knockout strain
of N. fumigata induced the fungus to produce the alkaloids rugulovasines A and B. The
biochemical activity and sequence in which easH and easQ functioned were also
studied. Typically, the eas genes present in N. fumigata control the reactions to turn
tryptophan and dimethylallylpyrophosphate to chanoclavine-I aldehyde and then to
festuclavine and fumigaclavine A, B, and C (Figure 2) (Robinson and Panaccione,
2015). While it is clear from the expression studies in N. fumigata that the easH and
easQ genes of P. camemberti are functional, P. camemberti does not produce ergot
alkaloids in culture nor were the alkaloids detected in any cheese samples obtained or
created. To explain this lack of ergot alkaloids in P. camemberti in light of the genetic
data, we looked at evolutionary data, taking into account the closely related
rugulovasine-producing strains of Penicillium spp. Differences in the eas gene clusters
between P. camemberti and P. biforme were studied through complementation and
mRNA expression studies to investigate a possible explanation. It was found that P.
camemberti encodes functional easE and dmaW genes but further investigation of the
easC gene is needed to fully understand if all the genes in the ergot alkaloid synthesis
gene cluster are functional.
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Rugulovasines
Structurally, rugulovasines are classified as indole alkaloids in the ergot family
that contain a spirocyclic butyrolactone subunit (Zhang et al., 2013). Rugulovasines are
unique as they occur as two racemic isomers, A and B, that are capable of being
interconverted by heating in polar solvents (Meurant, 2012). Ergot alkaloids are great
chemical structures to undergo biohalogenation as they contain nitrogen in their
chemical structure (Gribble, 2008). Thus, it there are also naturally-occurring chlorinated
and brominated forms of rugulovasine (De Medeiros et al., 2015).
While the health effects of the rugulovasines are largely understudied, a few
studies indicate they may induce negative heath consequences. Previous research
showed that ingestion of rugulovasines by day-old poultry caused acute toxicity effects
(Dorner et al., 1980). In fact, this toxicity was used as a bioassay to purify the
rugulovasines. It has also been reported that the rugulovasines caused decreased
blood pressure when administered to cats (Meurant, 2012). Our LC-MS data indicate
that P. biforme and the easH/easQ-transformed easA ko strain of N. fumigata are
capable of producing both rugulovasine A and B (Figure 6). This is evident as the
fragmentation spectra for both rugulovasine A and B match the fragmentation spectra of
rugulovasines from previous studies (De Medeiros et al., 2015). However, the
chlorinated and brominated forms of rugulovasine were not detected when analyzed on
LC-MS based on the absence of analytes of the predicted masses established in
analyses by De Medeiros et al. (2015). It is also pertinent to note that while
rugulovasines were detected in large quantities in our LC-MS data, they were not
detected on the HPLC with fluorescence detection (monitoring at excitation/emission
wavelengths of 272 nm/372 nm or 310 nm/410 nm, respectively). Future steps may be
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to monitor different combinations of excitation and emission wavelengths in order for the
rugulovasines to fluoresce for detection on the HPLC. It is also possible that the
particular structure of these compounds prevents or quenches fluorescence.
Proposed mechanism of rugulovasine biosynthesis
We hypothesize that EasQ, predicted by sequence analysis to be an aldehyde
dehydrogenase, oxidizes chanoclavine-I aldehyde to the corresponding carboxylic acid
(Figure 14). As the name indicates, an aldehyde dehydrogenase is capable of acting on
aldehydes, oxidizing the aldehyde to a carboxylic acid. The aldehyde dehydrogenase
family of enzymes are NADP-dependent that share the basic structural and functional
attributes that allow them to catalyze the oxidation of a number of different aliphatic and
aromatic aldehydes (Lindahl, 1992). Evidence that the P. camemberti easQ gene is
similar yet different from the other forms of aldehyde dehydrogenases can be observed
from the phylogenetic and sequence match data (Figure 14B). In fact, a close homolog
of easQ with two introns in identical position and phase is found in the P. camemberti
genome and has close homologs in several other members of the Trichocomaceae,
including N. fumigata. The data favor that easQ acts as the nomenclature indicates,
turning chanoclavine-I aldehyde into chanoclavine-I acid (Figure 15). Analysis of the
transformed chanoclavine-I aldehyde accumulating easA knockout strain of N. fumigata
with the easQ gene on LC-MS supports this proposed mechanism as copious amounts
of an analyte with the mass of [chanoclavine-l acid + H]+ (m/z 271) was detected (Figure
9). Whereas small quantities of this same metabolite were observed in the N. fumigata
easA knockout strain, the ratio of chanoclavine-I (resumed substrate) to the m/z 271
analyte (presumed product) increased significantly upon expression of easQ. These
results supported the hypothesis that EasQ may be acting on chanoclavine-l aldehyde
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and converting it to the corresponding carboxylic acid. The amounts of the m/z 271
analyte compared to chanoclavine-I were also compared to the levels of these analytes
found in the easA knockout strain of N. fumigata with the easH gene as well as the
chanoclavine-I aldehyde accumulating easA knockout strain of N. fumigata (Figure 9).
While there were trace amounts of the presumed chanoclavine-l acid found in the
chanoclavine-I aldehyde accumulating easA knockout strain of N. fumigata, the
increase in the analyte of this mass in the easQ-transformed strain as well as the ratios
between the aldehyde and the proposed acid are indicative of the actions of EasQ
(Figure 15). Furthermore, Blastp search has indicated that there is a distant easQ
homologue present in N. fumigata as well as in P. camemberti. The other P.
camemberti homologue, which is 58% identical in amino acid sequence to the product
of the easQ gene used in this study, may be the parent gene from which easQ was
neofunctionalized (Figure 14 A,B). Thus, the product of this gene in N. fumigata may be
responsible for the small background quantities of the analyte with the mass of
chanoclavine-I acid in N. fumigata. However, the data strongly favors that the P.
camemberti EasQ is capable of converting chanoclavine-l aldehyde to chanoclavine-l
acid (Figure 9).
EasH, a predicted dioxygenase, would oxidize the aromatic carbon customarily
labeled as carbon 10 in chanoclavine-I aldehyde or perhaps that same carbon in the
corresponding carboxylic acid, chanoclavine-I acid. Dehydration of the 10-hydroxylated
chanoclavine-I acid would result in the formation of rugulovasine A (Figure 15). The
literature supports that this proposed mechanism is possible but novel, as the product of
no other form of the easH gene has acted on this proposed substrate. Jakubczyk et al.
(2015) proposed three mechanisms by which EasH of the fungus Aspergillus japonicus
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might oxidize the very same carbon in a slightly different ergot alkaloid precursor to
result in formation of cycloclavine. That study outlined three potential mechanisms that
may be encoded for by the easH gene (Figure 16). The first two outlined mechanisms
propose that EasH may be abstractring a hydride ion (Figure 16A), or abstracting a
hydrogen ion from its substrate (Figure 16B). Figure 16C shows that EasH may be
hydroxylating or halogenating its substrate. Hydroxylation is the mechanism that is
consistent with our hypothesis for P. camemberti EasH, as it would explain
hydroxylating the chanoclavine-I acid produced from the actions of easQ
A study with another allele of easH from Claviceps purpurea stated that easH
has the ability to code for enzymes that can hydroxlate amino acids that are in the first
position of ergopeptines. The study also found that the product of that particular allele of
easH was capable of cyclolizying the ergopeptine classes that are naturally occurring
(Havemann et al., 2014). Figure 13C and D illustrates the phylogenetic relationships
between the easH alleles from these fungi as well as those other fungi that share a
similar easH gene with P. camemberti. The phylogenetic clustering of P. camemberti
easH with those involved in cycloclavine biosynthesis support the hypothesis that they
have similar activities on a similar substrate.
If EasH were to act on chanoclavine-l aldehyde (as opposed to it acid derivative
described above), we propose that the intermediate would essentially be chanoclavine-I
aldehyde with an additional oxygen at carbon 10, thus making its m/z around 271.
While the easH gene alone was successfully transformed into the chanoclavine-I
aldehyde-accumulating easA knockout strain of N. fumigata (Figure 6B), when analyzed
on LC-MS there were no notable traces of this proposed intermediate. It is possible that
EasQ needs to act on chanoclavine-I aldehyde first before EasH can undertake its
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oxidation mechanisms (Figure 15). It may also be that intermediate is unstable in this
form and therefore does not stay in solution long enough to be detected. The fact that
the production of rugulovasine was detected when both easH and easQ were
expressed supports the notion that they work together in catalyzing chanoclavine-I
aldehyde into rugulovasine.
Ancestral species of P.camemberti are rugulovasine producers
Phylogenetic analysis shows that P. biforme, P. fuscoglaucum and P. commune
are perhaps the ancestral strains of P. camemberti (Ropars et al., 2015; Polonelli et al.,
1987). P. biforme, P. fuscoglaucum and P. commune are known as common
contaminants of cheese and other food products. The close phylogenetic relationship
between P. biforme, P. fuscoglaucum and P. camemberti was confirmed by using 17
different microsatellite markers (Giraud et al., 2009). P. biforme and P. commune are
known for producing rugulovasines (Kozlovsky,1999).
There are two chemotypes of P. commune, with Chemotype I being associated
as a producer of cyclopenoxoic acid and rugulovasine and chemotype II producing
fumigoclavines. P. camemberti is thought to have descended from P. commune
chemotype I or the one that is known for producing rugulovasines (Frisvad and
Filtenborg, 1989). This hypothesis is supported by data from Polonelli et al. (1987) who
analyzed what appeared to be a P. camemberti mutant that produced the same
alkaloids as P. commune. It was determined that this “mutant” was actually in a P.
commune, thus P. commune must be the ancestor of P. camemberti (Polonelli et al.,
1987). All of these phylogenic lineages favor the notion that the ancestor to P.
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camemberti had the genetic capacity to produce rugulovasine but at some point in the
domestication of the commercial strain the fungus lost that ability.
Lack of ergot alkaloid production in P. camemberti
While the data suggest that the products of the P. camemberti easH and easQ
genes act on chanoclavine-l aldehyde to produce rugulovasines, ergot alkaloids were
not detected in any strain of P. camemberti. Interestingly enough, P. camemberti does
transcribe all of the eas genes in the ergot alkaloid synthesis gene cluster under the
cultural conditions commonly used in our analyses (Figure 9), which involved culturing
the fungus in malt extract medium without agitation at ambient temperature. Sequence
data collected on these transcripts indicated proper processing of mRNAs, eliminating
that step as a reason for the lack of ergot alkaloids in P. camemberti. P. biforme shares
a similar ergot alkaloid gene cluster with P. camemberti with the exception of a few
nucleotide differences (Figure 11). Because there were minor differences between the
P. camemberti easC, easE and dmaW genes in comparison to the P. biforme eas
genes, these genes were selected for complementation studies. The P. camemberti
dmaW and easE genes were found to be fully functional, as they were able to be
transformed into the N. fumigata the respective knockout strain and restore the fungus’s
ability to produce festuclavine C (Figure 12). However, attempts to express the P.
camemberti easC failed to result in accumulation of easC mRNA. One potential reason
for this observation is that expression of P. camemberti easC in N. fumigata may require
placing the coding sequences of the gene under the control of an N. fumigata promoter.
Implications
The collected data has shown an ancestral capacity of P. camemberti to produce
ergot alkaloids. The data suggested potential mechanisms of the novel P. camemberti
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easQ gene and the novel allele of easH and the role they play in the production of
rugulovasines. Moreover, while it may be reassuring to know that domesticated strains
of P. camemberti used for the production of camembert-type cheeses did not produce
any detectable ergot alkaloids, some Penicillium strain associated with dairy products
may have the ability to produce rugulovasines (Polonelli et al., 1987). While there is little
known about how rugulovasines may affect human health, the literature does indicate
that it is a compound that may have detrimental heath impacts if prolonged exposure
persists (Dorner et al., 1980; Meurant, 2012).
It is possible that P. biforme may produce rugulovasines as a means of defense
of resources and that P. camemberti does not need this defense as it is only found on
cheese products which have a defined microflora and are cultivated hygienically.
Another theory is that historically the rugulovasines may have made consumers of the
cheese sick, therefore strains of P. camemberti that were unable to produce these
alkaloids were selected. It is possible that there may be more to this observation and
therefore it should be further studied. Future studies to try to explain this phenomenon
would include sequencing and comparing the eas gene cluster of P. fuscoglaucum and
P. commune to try to pinpoint where this divergence may have occurred. Also, it is
pertinent to note that while P. biforme produces rugulovasines in culture, no alkaloids
were detected when P. biforme was grown on cheese substrates.
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Figures

Dopamine

Serotonin

Norepinephrine

Figure 1: Chemical structures of neurotransmitters dopamine, serotonin and
norepinephrine on the left. These neurotransmitters interact with neuroreceptors to
elicit a neuronal response in the body. Chemical structures of ergot alkaloids
chanoclavine-l aldehyde and rugulovasine A are pictured on the right. Ergot alkaloids
have a similar chemical backbone as the neurotransmitters, thus they can interact with
the neuroreceptors as well.
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Figure 2: Series of reactions catalyzed by the eas genes converting tryptophan and N-methyl DMAT to
chanoclavine-l aldehyde. This pathway is common to most ergot alkaloid producers, with chanoclavine-I
aldehyde acting as the branching point into more specialized alkaloids
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A

B
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Figure 3: A: The ergot alkaloid synthesis gene cluster from P. camemberti. Genes easC,
easF, easE, dmaW, and easD are also found in N. fumigata. The combination of easH and
easQ are novel to P. camemberti and P. biforme. B: Ergot alkaloid gene cluster found in P.
biforme. C: gene cluster found in N. fumigata. While the eas gene cluster is more extensive
in N. fumigata, it shares five of the same genes among P. camemberti and P. biforme.
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Table 1: Primer combinations, annealing temperature, and extension time for the various
PCR reactions.
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Table 2: Ergot alkaloid synthesis genes found in P. camemberti and their similarity to genes found
in other known alkaloid producing fungi. The P. camemberti genome was obtained through NCBI
and the individual genes were compared through NCBI Blastx. The function of these genes and
percent identity are shown below.
Gene

% Identity

Species

Function

Accession number

easQ

97%

Aspergillus flavus

aldehyde dehydrogenase

XP_002376976.1

easH

99%

Byssochlamys spectabilis

Phytanoyl-CoA dioxygenase

GAD93023.1

easC

86%

Penicillium roqueforti

Catalase haem-binding site

CDM36675.1

easF

93%

Penicillium roqueforti

SAM-dependent
methyltransferase, EasFtype

CDM36676.1

easE

94%

Penicillium roqueforti

Berberine/berberine-like

CDM36677.1

dmaW

93%

Penicillium roqueforti

Tryptophan
dimethylallyltransferase

CDM36678.1

easD

99%

Aspergillus lentulus

chanoclavine-I
dehydrogenase

GAQ03955.1
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Figure 4: P. camemberti easH and easQ were both present in the
transformed N. fumigata easA ko fungus.
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Figure 5. Extracted ion chromatogram m/z 269.2 from mass spectrometry analysis of N.
fumigata easA ko (A), the N. fumigata easA knockout transformed with easH and easQ (B),
and P. biforme (C).
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Figure 6: Mass spectrometry fragmentation patterns of rugulovasine (De Medeiros et. al.,
2015) and the N. fumigata easA ko transformed with easH and easQ.
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Figure 7: PCR evidence illustrating that fungal transformations were
successful. Primer sets for specific amplification of the genes were used in
conjunction with the transformed N. fumigata strains. A) presence of easH in
the N. fumigata easA ko strain. B) presence of easQ in the N. fumigata easA ko
strain. C) presence of dmaW in the N. fumigata dmaW ko strain. D) presence of
easE in the N. fumigata easE ko strain.
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Figure 8: cDNA of the easH/easQ transformed N. fumigata easA knockout. A) shows
presence of easH while B) shows easQ. Primers for easQ flanked an intron, and the size
(and DNA sequence) of the PCR product demonstrate it was derived from processed
mRNA..
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Ratio of Analytes at m/z 271.1 vs. m/z 255.1
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N. fumigata easA ko+easQ

Figure 9: 271.1/255.1 m/z ratio differences observed in the LC-MS data of N. fumigata
easA ko, N. fumigata easA ko+easH and N. fumigata easA ko+easQ. Brown-Forsythe
analysis indicates significant differences between A and B as indicated by p-value
further outlined in Table 3.
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Table 3: Calculated p-values by Brown-Forsythe analysis that show that there is a
difference in ratio of 271.1/255.1 m/z based on the strains analyzed. Asterisks
indicate significance.

Strains analyzed by LC-MS

p-Value

N. fumigata easA ko+ easQ vs. N. fumigata easA ko

0.002*

N. fumigata easA ko+ easQ vs. N. fumigata easA ko+ easH

0.007*

N. fumigata easA ko+ N. fumigata easA ko +easH

0.673
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Figure 10: RT-PCR of dmaW, easF, easC , easE, easD,easH and easQ transcripts from
P. camemberti NRRL strain 874 cDNA. All seven genes in the ergot alkaloid gene cluster
are being transcribed and expressed when the fungus was cultured in malt extract agar.
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Figure 11: A) Mutation sites of the P. camemberti eas gene cluster in comparison to P.
biforme as indicated with stars. Black stars indicate the mutations of the non coding region
and are outlined in B), white stars indicate the mutations within the coding regions and are
further outlined in C).
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Figure 12: HPLC of the P. camemeberti easE (blue) and dmaW (red) N.fumigata knockout
transformants in comparison to wild type N. fumigata (black). This analysis indicates that the
two transformants are producing fumigaclavine C (58.7), just in smaller quantities than the wild
type N. fumigata. EasE transformant also appears to less efficient at converting festuclavine to
fumigaclavine C, thus the larger peak at 43.8.
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Figure 13: Camembert cheese prepared with P. camemberi NRRL 874 and P. biforme NRRL
885. These products were analyzed on the LC- MS for ergot alkaloids.
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Figure 14: Phylogenetic analysis of the easQ and easH genes from P. camemberti and their
relationship to those of other fungi. A Phylogenetic relationship between the top NCBI blastp matches
of the P. camemberti easQ gene. It is notable that there is a paralog of the P. camemberti and P.
biforme easQ gene. B The numerical relationships between homologues of easQ from other fungi with
easQ of P. camemberti. C Phylogenetic relationship of P. camemberti easH and homologues from other
fungi. D Homologues of P. camemberti easH based on NCBI blastp search. It is interesting to note the
close relationship between P. camemberti easH and Aspergillus japonicus easH.
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10

rugulovasine
Figure 15: Proposed synthesis of rugulovasine from chanoclavine-l aldehyde. EasQ, predicted
by sequence analysis to be an aldehyde dehydrogenase, would oxidize the aldehyde to an acid.
EasH, a predicted dioxygenase, would oxidize the aromatic carbon. Dehydration would result in
the formation of rugulovasine.
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Figure 16: Proposed mechanisms of EasH activity as described by Jakubczyk et al. (2015) in
the fungus Aspergillus japonicus. A EasH may be abstractring a hydride ion, B EasH may be
abstracting a hydrogen ion from its substrate. C EasH may be hydroxylating or halogenating its
substrate. Hydroxylation is the mechanism that is consistent with our hypothesis for P.
camemberti EasH activity.
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